Wilfred Jelco Poppinga

Wilfred Jelco Poppinga

Auto-generated profile, based on publicly available information

Wilfred Jelco Poppinga

University of Groningen, Department of Molecular Pharmacology, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2014 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
AOAnouk Oldenburger
Anouk Oldenburger
WPWilfred J. Poppinga
Wilfred J. Poppinga
FKFleur Kos
Fleur Kos
HBHarold G. de Bruin
Harold G. de Bruin
WRWolter F. Rijks
Wolter F. Rijks
Martina SchmidtMartina Schmidt
Martina Schmidt
Airway epithelium, which forms the first barrier towards environmental insults, is disturbed by cigarette smoking, a major risk factor for developing chronic obstructive pulmonary disease (COPD). A-kinase anchoring proteins (AKAP) maintain endothelial barrier function and coordinate subcellular localization of protein kinase A (PKA). However, the role of AKAPs in epithelial barrier function is unknown. We studied the role of AKAPs in regulating human bronchial epithelial (Hogg JC, Timens W. Annu Rev Pathol 4: 435–459, 2009; HBE) barrier. Cigarette smoke extract (CSE) reduced barrier function in 16HBE cells and the expression of the adhesion molecule E-cadherin specifically at the cell membrane. In addition, CSE reduced the protein expression of the AKAP family member AKAP9 at the cell membrane. The expression of AKAP5 and AKAP12 was unaffected by CSE. AKAP9 interacted and colocalized with E-cadherin at the cell membrane, suggesting that the reduction of both proteins may be related. Interestingly, disruption of AKAP-PKA interactions by st-Ht31 prevented the CSE-induced reduction of E-cadherin and AKAP9 protein expression and subsequent loss of barrier function. Silencing of AKAP9 reduced the functional epithelial barrier and prevented the ability of st-Ht31 to restore membrane localization of E-cadherin. Our data suggest the possibility of a specific role for AKAP9 in the maintenance of the epithelial barrier. E-cadherin, but not AKAP9, protein expression was reduced in lung tissue from COPD patients compared with controls. However, AKAP9 mRNA expression was decreased in primary bronchial epithelial cells from current smokers compared with non/ex-smokers. In conclusion, our results indicate that AKAP proteins, most likely AKAP9, maintain the bronchial epithelial barrier by regulating the E-cadherin expression at the cell membrane.

3 May 2018 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
HZHaoxiao Zuo
Haoxiao Zuo
BHBing Han
Bing Han
WPWilfred J Poppinga
Wilfred J Poppinga
LRLennard Ringnalda
Lennard Ringnalda
LKLoes E M Kistemaker
Loes E M Kistemaker
Martina SchmidtMartina Schmidt
Martina Schmidt
Background and Purpose: cAMP is a central second messenger that broadly regulates cell function and can underpin pathophysiology. In chronic obstructive pulmonary disease, a lung disease primarily provoked by cigarette smoke (CS), the activation of cAMP‐dependent pathways, via inhibition of hydrolyzing PDEs, is a major therapeutic strategy. Mechanisms that disrupt cAMP signalling in airway cells, in particular regulation of endogenous PDEs, are poorly understood.Experimental Approach: We used a novel Förster resonance energy transfer (FRET) based cAMP biosensor in mice in vivo, ex vivo precision cut lung slices (PCLS) and in human cell models, in vitro, to track the effects of CS exposure.Key Results: Under fenoterol stimulation, FRET responses to cilostamide were significantly increased in in vivo, ex vivo PCLS exposed to CS and in human airway smooth muscle cells exposed to CS extract. FRET signals to rolipram were only increased in the in vivo CS model. Under basal conditions, FRET responses to cilostamide and rolipram were significantly increased in in vivo, ex vivo PCLS exposed to CS. Elevated FRET signals to rolipram correlated with a protein up‐regulation of PDE4 subtypes. In ex vivo PCLS exposed to CS extract, rolipram reversed down‐regulation of ciliary beating frequency, whereas only cilostamide significantly increased airway relaxation of methacholine pre‐contracted airways.Conclusion and Implications: Exposure to CS, in vitro or in vivo, up‐regulated expression and activity of both PDE3 and PDE4, which affected real‐time cAMP dynamics. These mechanisms determine the availability of cAMP and can contribute to CS‐induced pulmonary pathophysiology.

1 December 2014 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
WPW. J. Poppinga
W. J. Poppinga
PMP. Muñoz‐Llancao
P. Muñoz‐Llancao
CGC. González‐Billault
C. González‐Billault
MSM. Schmidt
M. Schmidt

15 April 2015 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
WPWilfred J. Poppinga
Wilfred J. Poppinga
IHIrene H. Heijink
Irene H. Heijink
LHLaura J. Holtzer
Laura J. Holtzer
PSPhilipp Skroblin
Philipp Skroblin
EKEnno Klussmann
Enno Klussmann
Martina SchmidtMartina Schmidt
Martina Schmidt
β2-Agonist inhibitors can relieve chronic obstructive pulmonary disease (COPD) symptoms by stimulating cyclic AMP (cAMP) signaling. A-kinase-anchoring proteins (AKAPs) compartmentalize cAMP signaling by establishing protein complexes. We previously reported that the β2-agonist fenoterol, direct activation of protein kinase A (PKA), and exchange factor directly activated by cAMP decrease cigarette smoke extract (CSE)-induced release of neutrophil attractant interleukin-8 (IL-8) from human airway smooth muscle (ASM) cells. In the present study, we tested the role of AKAPs in CSE-induced IL-8 release from ASM cells and assessed the effect of CSE on the expression levels of different AKAPs. We also studied mRNA and protein expression of AKAPs in lung tissue from patients with COPD. Our data show that CSE exposure of ASM cells decreases AKAP5 and AKAP12, both capable of interacting with β2-adrenoceptors. In lung tissue of patients with COPD, mRNA levels of AKAP5 and AKAP12 were decreased compared with lung tissue from controls. Using immunohistochemistry, we detected less AKAP5 protein in ASM of patients with COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II compared with control subjects. St-Ht31, which disrupts AKAP-PKA interactions, augmented CSE-induced IL-8 release from ASM cells and diminished its suppression by fenoterol, an effect mediated by disturbed ERK signaling. The modulatory role of AKAP-PKA interactions in the anti-inflammatory effects of fenoterol in ASM cells and the decrease in expression of AKAP5 and AKAP12 in response to cigarette smoke and in lungs of patients with COPD suggest that cigarette smoke-induced changes in AKAP5 and AKAP12 in patients with COPD may affect efficacy of pharmacotherapy.

1 September 2013 in Neuropharmacology
Verified
Journal Article
Closed access
MYMakiko Yamada
Makiko Yamada
YKYukie Kawahara
Yukie Kawahara
FKFumi Kaneko
Fumi Kaneko
YKYuki Kishikawa
Yuki Kishikawa
NSNaoki Sotogaku
Naoki Sotogaku
ANAkinori Nishi
Akinori Nishi

1 December 2014 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
HAHatem Alkhouri
Hatem Alkhouri
WPWilfred Jelco Poppinga
Wilfred Jelco Poppinga
NTNavessa Padma Tania
Navessa Padma Tania
AAAlaina Ammit
Alaina Ammit
MSMichael Schuliga
Michael Schuliga